News Summary: KV Pharma files Chapter 11 - Businessweek
08/06/12
![]()
News Summary: KV Pharma files Chapter 11
Businessweek
CHAPTER 11: K-V Pharmaceutical Co. filed for Chapter 11 bankruptcy protection Saturday, saying weak sales of its preterm birth drug Makena and regulatory sanctions are hurting its business. REORGANIZING: The St. Louis company plans to stay in ...
[more]
Businessweek
CHAPTER 11: K-V Pharmaceutical Co. filed for Chapter 11 bankruptcy protection Saturday, saying weak sales of its preterm birth drug Makena and regulatory sanctions are hurting its business. REORGANIZING: The St. Louis company plans to stay in ...
- Feeds Categories: